[1]
Leqi Shen, “HR-Positive Breast Cancer and New Potentially Synergistic Approaches with CDK Inhibition of the Retinoblastoma Protein and CAR T-Cell Immunotherapy”, JIMR, vol. 2, no. 11, pp. 24–27, Nov. 2023.